Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials.
Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Department of Internal Medicine, Medical Center Slotervaart, Louwesweg 6, 1066 EC Amsterdam, the Netherlands. Electronic address: l.p.elbers@amc.uva.nl.
Laura P B
LP
Elbers
Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Electronic address: b.sjouke@amc.uva.nl.
Barbara
B
Sjouke
Inserm, CIC-P 14-33 and U1116, Nancy, France; CHU Nancy, Pôle de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, France; Université de Lorraine, France. Electronic address: f.zannad@chru-nancy.fr.
Faïez
F
Zannad
Section of Cardiology, Department of Medicine, University of Verona, Verona, Italy. Electronic address: mariantonietta.cicoira@univr.it.
Mariantonietta
M
Cicoira
Section of Cardiovascular Diseases, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Study of Brescia, Italy. Electronic address: enrico.vizzardi@tin.it.
Enrico
E
Vizzardi
Department of Internal Medicine I - Cardiology, University Hospital Olomouc and Palacký University Faculty of Medicine and Dentistry, Olomouc, Czech Republic. Electronic address: vaclavik.j@centrum.cz.
Jan
J
Václavík
Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands; Department of Internal Medicine, Medical Center Slotervaart, Louwesweg 6, 1066 EC Amsterdam, the Netherlands. Electronic address: v.e.gerdes@amc.uva.nl.
Victor E A
VE
Gerdes
Research Centre on Thromboembolic Disorders and Antithrombotic Therapies, Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy. Electronic address: alessandro.squizzato@uninsubria.it.
Alessandro
A
Squizzato
D000450:Aldosterone / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood / Q000139:chemically induced / Q000150:complications / Q000401:mortality; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced* / Q000150:complications / Q000401:mortality; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D006929:Hyperaldosteronism / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D013927:Thrombosis / Q000097:blood / Q000139:chemically induced* / Q000150:complications / Q000401:mortality
D000451:Mineralocorticoid Receptor Antagonists; D000450:Aldosterone
Aldosterone; Bleeding; Mineralocorticoid receptor antagonists; Thrombosis